{
    "organizations": [],
    "uuid": "8c12b4432db2b8496205d375058734aecaae587c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-compugroup-medical-q4-revenue-of-e/brief-compugroup-medical-q4-revenue-of-eur-164-million-up-6-pct-idUSFWN1PS1M7",
    "ord_in_thread": 0,
    "title": "BRIEF-CompuGroup Medical Q4 Revenue Of EUR 164 Million, Up 6 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 5 (Reuters) - CompuGroup Medical SE:\n* Q4 REVENUE OF EUR 164 MILLION, UP 6 PERCENT VERSUS EUR 154 MILLION IN THE SAME PERIOD LAST YEAR\n* EBITDA INCREASED FROM EUR 36 MILLION IN 2016 TO EUR 37 MILLION IN 2017\n* FOR 2018, CGM EXPECTS THE CONTINUATION OF ITS GROWTH PATH AND AN IMPROVEMENT IN PROFITABILITY\n* OUTLOOK 2018: REVENUES OF BETWEEN EUR 700 MILLION AND EUR 730 MILLION\n* OUTLOOK 2018: EBITDA OF BETWEEN EUR 175 MILLION AND EUR 190 MILLION Source text - bit.ly/2E1m4ah Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-05T15:04:00.000+02:00",
    "crawled": "2018-02-07T00:10:04.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "compugroup",
        "medical",
        "se",
        "q4",
        "revenue",
        "eur",
        "million",
        "percent",
        "versus",
        "eur",
        "million",
        "period",
        "last",
        "year",
        "ebitda",
        "increased",
        "eur",
        "million",
        "eur",
        "million",
        "cgm",
        "expects",
        "continuation",
        "growth",
        "path",
        "improvement",
        "profitability",
        "outlook",
        "revenue",
        "eur",
        "million",
        "eur",
        "million",
        "outlook",
        "ebitda",
        "eur",
        "million",
        "eur",
        "million",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}